Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 6 studies | 63% ± 27% | |
non-classical monocyte | 3 studies | 22% ± 4% | |
dendritic cell | 3 studies | 22% ± 3% |
Insufficient scRNA-seq data for expression of GNGT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 81.11 | 647 / 653 | 97% | 3.79 | 589 / 605 |
lung | 100% | 182.93 | 578 / 578 | 89% | 3.48 | 1032 / 1155 |
breast | 97% | 54.32 | 447 / 459 | 91% | 2.57 | 1012 / 1118 |
kidney | 99% | 70.54 | 88 / 89 | 86% | 4.33 | 778 / 901 |
uterus | 99% | 59.54 | 169 / 170 | 81% | 2.80 | 372 / 459 |
ovary | 94% | 41.13 | 169 / 180 | 77% | 1.85 | 333 / 430 |
brain | 79% | 36.34 | 2090 / 2642 | 90% | 3.50 | 631 / 705 |
stomach | 95% | 40.33 | 342 / 359 | 72% | 2.11 | 205 / 286 |
bladder | 100% | 67.14 | 21 / 21 | 66% | 2.04 | 331 / 504 |
intestine | 95% | 71.55 | 922 / 966 | 69% | 1.76 | 362 / 527 |
prostate | 98% | 66.62 | 241 / 245 | 66% | 1.26 | 329 / 502 |
esophagus | 93% | 39.67 | 1349 / 1445 | 65% | 1.35 | 119 / 183 |
adrenal gland | 99% | 57.50 | 256 / 258 | 53% | 1.19 | 121 / 230 |
pancreas | 62% | 17.19 | 203 / 328 | 90% | 3.24 | 160 / 178 |
liver | 72% | 25.66 | 162 / 226 | 52% | 1.17 | 212 / 406 |
skin | 38% | 8.91 | 683 / 1809 | 69% | 2.68 | 328 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.82 | 29 / 29 |
peripheral blood | 100% | 533.47 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 538.39 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 65.48 | 1162 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 4.87 | 43 / 45 |
heart | 94% | 43.80 | 810 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 69% | 29.49 | 925 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 1.23 | 22 / 80 |
muscle | 27% | 6.82 | 217 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007602 | Biological process | phototransduction |
GO_0005834 | Cellular component | heterotrimeric G-protein complex |
GO_0031681 | Molecular function | G-protein beta-subunit binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | GNGT2 |
Protein name | Guanine nucleotide-binding protein subunit gamma Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 (G gamma-C) (G-gamma-8) (G-gamma-9) (Guanine nucleotide binding protein gamma transducing activity polypeptide 2) |
Synonyms | GNG8 GNGT8 GNG9 |
Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. . |
Accessions | ENST00000507680.6 O14610 ENST00000511277.5 ENST00000503070.5 ENST00000511673.1 D6RDH5 ENST00000515635.5 ENST00000300406.6 |